NO20064031L - Esterderivater av thein og deres terapeutiske anvendelse - Google Patents

Esterderivater av thein og deres terapeutiske anvendelse

Info

Publication number: NO20064031L
Authority: NO; Norway
Prior art keywords: alkyl; thein; therapeutic use; optionally substituted; ester derivatives
Prior art date: 2004-03-04

Application number

NO20064031A

Other languages

English (en)

Norwegian (no)

Inventor

Andrew Douglas Baxter

Andrea Walmsley

Original Assignee

Sosei R & D Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-03-04

Filing date

2006-09-07

Publication date

2006-09-15

2006-09-07 Application filed by Sosei R & D Ltd filed Critical Sosei R & D Ltd

2006-09-15 Publication of NO20064031L publication Critical patent/NO20064031L/no

Links

230000001225 therapeutic effect Effects 0.000 title 1
125000000217 alkyl group Chemical group 0.000 abstract 5
230000003110 anti-inflammatory effect Effects 0.000 abstract 1
229910052799 carbon Inorganic materials 0.000 abstract 1
150000001875 compounds Chemical class 0.000 abstract 1
229910052736 halogen Inorganic materials 0.000 abstract 1
150000002367 halogens Chemical class 0.000 abstract 1
125000005842 heteroatom Chemical group 0.000 abstract 1
229910052739 hydrogen Inorganic materials 0.000 abstract 1
229910052760 oxygen Inorganic materials 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1
239000012453 solvate Substances 0.000 abstract 1
229910052717 sulfur Inorganic materials 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C66/00—Quinone carboxylic acids
- C07C66/02—Anthraquinone carboxylic acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/04—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D307/10—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D307/12—Radicals substituted by oxygen atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D309/10—Oxygen atoms

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Immunology (AREA)
Rheumatology (AREA)
Physical Education & Sports Medicine (AREA)
Orthopedic Medicine & Surgery (AREA)
Pulmonology (AREA)
Dermatology (AREA)
Pain & Pain Management (AREA)
Urology & Nephrology (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Transplantation (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Furan Compounds (AREA)
Pyrane Compounds (AREA)

NO20064031A 2004-03-04 2006-09-07 Esterderivater av thein og deres terapeutiske anvendelse NO20064031L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GBGB0404953.2A GB0404953D0 (en)	2004-03-04	2004-03-04	Pro-drugs
PCT/GB2005/000832 WO2005085170A1 (en)	2004-03-04	2005-03-04	Ester derivatives of rhein and their therapeutic use

Publications (1)

Publication Number	Publication Date
NO20064031L true NO20064031L (no)	2006-09-15

Family

ID=32088751

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20064031A NO20064031L (no)	2004-03-04	2006-09-07	Esterderivater av thein og deres terapeutiske anvendelse

Country Status (14)

Country	Link
US (1)	US7728035B2 (pt)
EP (1)	EP1723097A1 (pt)
JP (1)	JP4478713B2 (pt)
KR (1)	KR20070010142A (pt)
CN (1)	CN1938258A (pt)
AU (1)	AU2005219642B2 (pt)
BR (1)	BRPI0508352A (pt)
CA (1)	CA2558082A1 (pt)
GB (1)	GB0404953D0 (pt)
IL (1)	IL177752A0 (pt)
MX (1)	MXPA06010058A (pt)
NO (1)	NO20064031L (pt)
WO (1)	WO2005085170A1 (pt)
ZA (1)	ZA200607386B (pt)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB0622479D0 (en) *	2006-11-10	2006-12-20	Sosei R & D Ltd	Novel salts and their therapeutic use
CN101735271A (zh) *	2008-11-05	2010-06-16	上海慈瑞医药科技有限公司	具有趋骨性的双膦酸大黄酸醚衍生物及其制备方法
CN102225896B (zh) *	2011-04-07	2013-10-30	栗进才	大黄酸的醚衍生物以及它们的治疗用途
CN102552430A (zh) *	2011-12-03	2012-07-11	彭旦明	一种抑制瘢痕的有效部位群及其制备方法
CN102603575B (zh) *	2012-01-04	2014-08-13	丛晓东	大精酸共晶物、其制备方法、纯化方法及其在制备治疗糖尿病并发症药物中的应用
AU2013290277B2 (en) *	2012-07-10	2016-07-21	Children's Healthcare Of Atlanta, Inc.	Anthraquinone analogs and methods of making and using thereof
CN104547207A (zh) *	2015-01-29	2015-04-29	陈文斌	消除陈旧性疤痕的中药外敷制剂及制备方法
CN108349867B (zh) *	2015-08-17	2021-03-09	安成生物科技股份有限公司	用于抑制asc的表达、nlrp3的表达和/或nlrp3炎性复合体的形成的双醋瑞因或其类似物
CN106619503B (zh) *	2016-09-23	2019-09-13	辽宁大学	一种大黄酸酰胺类衍生物纳米混悬剂及其制备方法和应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ZA761627B (en) *	1976-03-16	1978-01-25	C Friedmann	Improvements in or relating to the treatment of arthritis
JPS58225015A (ja) *	1983-02-25	1983-12-27	プロツタ−・エス・ピ−・エ−	硬化症治療薬
IT1283772B1 (it) *	1996-07-31	1998-04-30	Medidom Lab	Procedimento per la preparazione di reina e diacereina
FR2757397B1 (fr)	1996-12-23	1999-03-05	Mazal Pharma	Composition pharmaceutique a base de rheine ou de diacerheine a biodisponibilite amelioree

2004
- 2004-03-04 GB GBGB0404953.2A patent/GB0404953D0/en not_active Ceased
2005
- 2005-03-04 BR BRPI0508352-4A patent/BRPI0508352A/pt not_active IP Right Cessation
- 2005-03-04 AU AU2005219642A patent/AU2005219642B2/en not_active Ceased
- 2005-03-04 EP EP05726943A patent/EP1723097A1/en not_active Withdrawn
- 2005-03-04 MX MXPA06010058A patent/MXPA06010058A/es not_active Application Discontinuation
- 2005-03-04 CA CA002558082A patent/CA2558082A1/en not_active Abandoned
- 2005-03-04 ZA ZA200607386A patent/ZA200607386B/en unknown
- 2005-03-04 KR KR1020067020192A patent/KR20070010142A/ko not_active Ceased
- 2005-03-04 CN CNA2005800099641A patent/CN1938258A/zh active Pending
- 2005-03-04 JP JP2007501352A patent/JP4478713B2/ja not_active Expired - Lifetime
- 2005-03-04 US US10/591,157 patent/US7728035B2/en not_active Expired - Fee Related
- 2005-03-04 WO PCT/GB2005/000832 patent/WO2005085170A1/en not_active Ceased
2006
- 2006-08-29 IL IL177752A patent/IL177752A0/en unknown
- 2006-09-07 NO NO20064031A patent/NO20064031L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
EP1723097A1 (en)	2006-11-22
JP4478713B2 (ja)	2010-06-09
IL177752A0 (en)	2006-12-31
AU2005219642B2 (en)	2009-04-23
CA2558082A1 (en)	2005-09-15
US20070185036A1 (en)	2007-08-09
MXPA06010058A (es)	2007-05-10
AU2005219642A1 (en)	2005-09-15
WO2005085170A1 (en)	2005-09-15
BRPI0508352A (pt)	2007-07-31
JP2007526293A (ja)	2007-09-13
CN1938258A (zh)	2007-03-28
ZA200607386B (en)	2008-05-28
GB0404953D0 (en)	2004-04-07
KR20070010142A (ko)	2007-01-22
US7728035B2 (en)	2010-06-01

Legal Events

Date	Code	Title	Description
2010-11-01	FC2A	Withdrawal, rejection or dismissal of laid open patent application

Publication	Publication Date	Title
NO20072978L (no)	2007-06-27	Nye betuinderivater, preparat derav og anvendelse derav
CY1121699T1 (el)	2020-07-31	Ενωσεις τριαζινης ως αναστολεις κινασης ρ13 και mtor
MX2021009763A (es)	2021-09-08	Derivados de 3-(1-oxo-5-(piperidin-4-il)isoindolin-2-il)piperidina -2,6-diona y usos de los mismos.
CY1112826T1 (el)	2016-02-10	[4-(6-αλογονο-7-υποκατεστημενες-2,4-διοξο-1,4-διϋδρο-2η-κιναζολιν-3-υλ)-φαινυλ]-5-χλωρο-θειοφαιν-2-υλ-σουλφονυλουριες και μορφες και μεθοδοι που σχετιζονται με αυτες
ATE517882T1 (de)	2011-08-15	Chinolinderivate
NO20081970L (no)	2008-06-16	Sulfonamidderivat med PGD2-reseptorantagonistaktivitet
NO20074620L (no)	2007-11-07	Spiroheterocykliske forbindelser og deres anvendelse som medikamenter
DK1539753T3 (da)	2010-01-04	Pyrazolo(3,4B9pyridin-forbindelser og deres anvendelse som phosphodiesterase-inhibitorer
NO20051165L (no)	2005-03-04	Benzotiazolderivater som har -adrenoerseptorantagonist aktivitet
EA201290260A1 (ru)	2013-12-30	Бензимидазол-имидазольные производные
EA200500304A1 (ru)	2005-10-27	Производные 3-(сульфонамидоэтил)индола, предназначенные для использования в качестве миметиков глюкокортикоидов при лечении воспалительных, аллергических и пролиферативных заболеваний
NO20071703L (no)	2007-07-04	Kinazolinderivater
NZ561747A (en)	2010-03-26	(Pyrrol-2-ylmethyl)-indol-1-yl-acetic acid derivatives with PGD2 antagonist activity
NO20073465L (no)	2002-12-12	Benzotiazol-derivater
ATE556058T1 (de)	2012-05-15	1-(2h)-isochinolonderivat
NO20082101L (no)	2008-08-15	Pyrido-, pyrazo- og pyrimido-pyrimidinderivater som mTor inhibitorer
ATE540928T1 (de)	2012-01-15	Isochinolinverbindungen und ihre medizinische verwendung
NO20064599L (no)	2006-12-08	Substituerte morfolin- og tiomorfolinderivater
NO20055568L (no)	2006-01-20	Substituerte 1,4-diazepiner og anvendelser derav
DE602004015316D1 (de)	2008-09-04	Phenäthanolaminderivate zur behandlung von krankheiten der atemwege
WO2007143523A3 (en)	2008-06-12	Fused, tricyclic sulfonamide inhibitors of gamma secretase
NO20056192L (no)	2005-12-27	Kapaseinhibitorer og anvendelse derav
NO20053133L (no)	2005-07-15	Kjemiske forbindelser.
NO20064297L (no)	2006-11-23	Aminoalkoholforbindelse
AR051413A1 (es)	2007-01-10	Piridinureas de antranilamida como inhibidores de la quinasa receptora del factor de crecimiento vascular endotelial (vegf)